Drug
Insulin Degludec Insulin Aspart
Insulin Degludec Insulin Aspart: highest development phase Phase 3, developed by Novo Nordisk. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Novo Nordisk
Trials
| Drug | Phase | Indication |
|---|---|---|
| insulin degludec/insulin aspart NCT01835431 | Phase 3 | Diabetes |
Latest
No recent events.
Follow Insulin Degludec Insulin Aspart on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.